510(k) K142516
K142516 is an FDA 510(k) premarket notification submitted by Reciprocal Labs Corporation for the device "Propeller System". The FDA issued a decision of Substantially Equivalent on May 15, 2015. The device falls under product code CAF (Nebulizer (Direct Patient Interface)), a Class II device regulated under 21 CFR 868.5630. Reciprocal Labs Corporation has 5 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 15, 2015
- Date Received
- Sep 8, 2014
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Nebulizer (Direct Patient Interface)
- Device Class
- Class II
- Regulation Number
- 868.5630
- Review Panel
- AN
- Submission Type
- 510(k)